SCHEMBL10049153

SCHEMBL10049153

CN(C)c1ccc(-c2nc3cnccn3c2NCC(=O)N2CCN(C(=O)C3CCCO3)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 9/20 0.47
ALDH1A1 P00352 4/20 0.47
TLR9 Q9NR96 3/20 0.47
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MAPT P10636 6/20 0.47
KDM4E B2RXH2 5/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
TP53 P04637 2/20 0.45
RXFP1 Q9HBX9 1/20 0.45
CASP1 P29466 3/20 0.45
CASP7 P55210 3/20 0.45
HPGD P15428 3/20 0.45
HSD17B10 Q99714 2/20 0.45
ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10049215 0.90 GAA (0.55) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL14963786 0.90 KCNK3 (0.49) GAAALDH1A1TLR9MEN1HTT
SCHEMBL10048888 0.88 GAA (0.44) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL10049163 0.88 GAA (0.54) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL14963816 0.85 GAA (0.45) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL10049221 0.85 GAA (0.47) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL10049150 0.85 GAA (0.52) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL10049158 0.83 GAA (0.51) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL10049151 0.82 GAA (0.47) GAAALDH1A1TLR9MEN1LMNA
SCHEMBL10049165 0.82 GAA (0.49) GAAALDH1A1TLR9MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131073-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS MERCK SHARP & DOHME CORP. 2013-05-23 US disclosed
US-20130131073-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS MERCK SHARP & DOHME CORP. 2013-05-23 US disclosed
WO-2012018665-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS SCHERING CORPORATION (US) 2012-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131073-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS MRPL21, ARG1, RPS4Y1 GAA 1859/4885ALDH1A1 1069/4885TLR9 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.